- Home
- IMNM vs NEOG Comparison
IMNM vs NEOG Comparison
Compare IMNM & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- NEOG
- Stock Information
- Founded
- IMNM 2006
- NEOG 1981
- Country
- IMNM United States
- NEOG United States
- Employees
- IMNM N/A
- NEOG N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IMNM Health Care
- NEOG Health Care
- Exchange
- IMNM Nasdaq
- NEOG Nasdaq
- Market Cap
- IMNM 945.8M
- NEOG 1.1B
- IPO Year
- IMNM 2020
- NEOG 1989
- Fundamental
- Price
- IMNM $10.60
- NEOG $4.74
- Analyst Decision
- IMNM Strong Buy
- NEOG Buy
- Analyst Count
- IMNM 5
- NEOG 3
- Target Price
- IMNM $26.40
- NEOG $7.50
- AVG Volume (30 Days)
- IMNM 965.4K
- NEOG 5.1M
- Earning Date
- IMNM 08-11-2025
- NEOG 07-29-2025
- Dividend Yield
- IMNM N/A
- NEOG N/A
- EPS Growth
- IMNM N/A
- NEOG N/A
- EPS
- IMNM N/A
- NEOG N/A
- Revenue
- IMNM $10,938,000.00
- NEOG $905,996,000.00
- Revenue This Year
- IMNM N/A
- NEOG N/A
- Revenue Next Year
- IMNM $259.34
- NEOG N/A
- P/E Ratio
- IMNM N/A
- NEOG N/A
- Revenue Growth
- IMNM N/A
- NEOG N/A
- 52 Week Low
- IMNM $5.15
- NEOG $3.87
- 52 Week High
- IMNM $16.81
- NEOG $18.58
- Technical
- Relative Strength Index (RSI)
- IMNM 60.20
- NEOG 41.45
- Support Level
- IMNM $10.33
- NEOG $4.71
- Resistance Level
- IMNM $11.08
- NEOG $5.47
- Average True Range (ATR)
- IMNM 0.60
- NEOG 0.24
- MACD
- IMNM 0.04
- NEOG -0.01
- Stochastic Oscillator
- IMNM 72.31
- NEOG 14.37
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About NEOG Neogen Corporation
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.